Breast pain and mammographic density increase as a consequence of raloxifene therapy

J Endocrinol Invest. 2002 Jun;25(6):564-6. doi: 10.1007/BF03345502.

Abstract

A 55-yr-old post-menopausal woman with osteopenia and no history of breast disease is presented. She was placed on raloxifene HCl 60 mg and soon after developed severe breast pain. The follow-up mammogram, performed prematurely at 6 months, showed a marked increase in breast density. Therapy was accordingly stopped and mastodynia subsided. The patient's mammogram regressed to pre-treatment status after 6 months off-therapy.

Publication types

  • Case Reports

MeSH terms

  • Bone Diseases, Metabolic / drug therapy
  • Breast / pathology*
  • Female
  • Humans
  • Mammography*
  • Middle Aged
  • Pain*
  • Raloxifene Hydrochloride / adverse effects*
  • Selective Estrogen Receptor Modulators / adverse effects*

Substances

  • Selective Estrogen Receptor Modulators
  • Raloxifene Hydrochloride